SMO and Hepatic fibrosis: Crucially, we provide molecular evidence that is consistent with the interpretation that these therapeutic benefits are associated with an upstream effect on the CK2α/SMO complex, moving beyond the general anti-inflammatory or antioxidant mechanisms often attributed to natural products and suggesting a new potential strategy for the targeted therapy of liver fibrosis.